The Real-World Safety and Effectiveness of Prochlorperazine in Indian Patients with Dizziness.
Conclusion: Prochlorperazine was well-tolerated in the management of acute dizziness when administered at a mean dose of 14.9 mg/day, and mean duration of 7.2 days. Additionally, prochlorperazine was effective in providing significant symptomatic relief from dizziness and associated vomiting and nausea.
PMID: 32009365 [PubMed - in process]
Source: Journal of the Association of Physicians of India - Category: General Medicine Tags: J Assoc Physicians India Source Type: research
More News: Drugs & Pharmacology | General Medicine | Headache | India Health | Migraine | Prochlorperazine | Study | Women